MicroRNA-361-5p Alleviates Leydig Cell Apoptosis and Promotes Cell Growth by Targeting PIAS1 in Late-Onset Hypogonadism
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01174-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Xunrong Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Nantong University, 9 Qiangyuan Road, Nantong, 226001, China. Hauptthemen laut MEDLINE: MicroRNAs, Leydig Cells, Apoptosis, Protein Inhibitors of Activated STAT. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Late-onset hypogonadism (LOH) is an age-related syndrome characterized by deficiency of serum testosterone produced by Leydig cells. Previous evidence suggested that microRNA (miR)-361-3p can serve as a promising biomarker for LOH. Nonetheless, its detailed function and molecular mechanism in LOH remain unclarified. The 24-month-old male mice were selected as an animal LOH model, and mouse Leydig cell line TM3 was stimulated with H2O2. ELISA was employed for testosterone level evaluation. Hematoxylin-eosin staining was implemented for histologic analysis of mouse testicular tissues. Western blotting and RT-qPCR were utilized for evaluating molecular protein and RNA expression, respectively. Functional experiments were conducted to test miR-361-5p roles. Luciferase reporter assay was for verifying the interaction between miR-361-5p and protein inhibitor of activated STAT 1 (PIAS1). miR-361-5p displayed a decreased level in the testes of LOH mice. Overexpressing miR-361-5p attenuated Leydig cell loss in the testis and elevated serum and intratesticular testosterone levels in LOH mice. H2O2 stimulation impaired TM3 cell viability, proliferation and intracellular testosterone production and enhanced cell apoptosis. miR-361-5p targeted PIAS1 in TM3 cell. PIAS1 upregulation counteracted miR-361-5p overexpression-mediated alleviation of cell apoptosis and elevation of testosterone synthesis in H2O2-stimualetd TM3 cells. miR-361-5p ameliorates LOH progression by increasing testosterone production and alleviate Leydig cell apoptosis via downregulation of PIAS1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College of Nantong University, 9 Qiangyuan Road, Nantong, 226001, China.
- Department of Urology, The Affiliated Dongtai Hospital of Nantong University, Kangfu West Rord, Dongtai, Yancheng, 224200, China.
- Medical College of Nantong University, 9 Qiangyuan Road, Nantong, 226001, China. n.feng@njmu.edu.cn.
- Department of Urology, Jiangnan University Medical Center, Wuxi, 214000, China. n.feng@njmu.edu.cn.
- Wuxi School of Medicine, Jiangnan University, Wuxi, 214000, China. n.feng@njmu.edu.cn.
- Department of Urology, Nanjing Medical University, Wuxi No.2 Hospital, Wuxi, 214000, China. n.feng@njmu.edu.cn.
Zitieren
APA
Zhou, X., Ben, C., Wu, D., Xia, A., Chang, P., He, B., Feng, N., & Wu, C. (2025). MicroRNA-361-5p Alleviates Leydig Cell Apoptosis and Promotes Cell Growth by Targeting PIAS1 in Late-Onset Hypogonadism. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01174-x
Vancouver
Zhou X, Ben C, Wu D, Xia A, Chang P, He B, et al. MicroRNA-361-5p Alleviates Leydig Cell Apoptosis and Promotes Cell Growth by Targeting PIAS1 in Late-Onset Hypogonadism. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01174-x
BibTeX
@article{Zhou2025,
author = {Zhou, Xunrong and Ben, Chunsheng and Wu, Dong and Xia, Anle and Chang, Ping'an and He, Bin and Feng, Ninghan and Wu, Cheng},
title = {MicroRNA-361-5p Alleviates Leydig Cell Apoptosis and Promotes Cell Growth by Targeting PIAS1 in Late-Onset Hypogonadism},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01174-x}
}
EUVIMED